A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design.
Chen HW, Liu SJ, Liu HH, Kwok Y, Lin CL, Lin LH, Chen MY, Tsai JP, Chang LS, Chiu FF, Lai LW, Lian WC, Yang CY, Hsieh SY, Chong P, Leng CH.
Chen HW, et al. Among authors: chang ls.
Vaccine. 2009 Feb 25;27(9):1400-9. doi: 10.1016/j.vaccine.2008.12.043. Epub 2009 Jan 15.
Vaccine. 2009.
PMID: 19150476